proglumide has been researched along with c-peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lüthen, R; Niederau, C; Niederau, M; Rovati, L; Schwarzendrube, J; Strohmeyer, G | 1 |
| Beglinger, C; Fried, M; Jansen, JB; Keller, U; Lamers, CB; Schwizer, W | 1 |
1 trial(s) available for proglumide and c-peptide
| Article | Year |
|---|---|
Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide.
Topics: Adult; C-Peptide; Cholecystokinin; Dietary Carbohydrates; Eating; Gastric Emptying; Glucose; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Middle Aged; Proglumide; Receptors, Cholecystokinin; Time Factors | 1991 |
1 other study(ies) available for proglumide and c-peptide
| Article | Year |
|---|---|
Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
Topics: Administration, Oral; Adult; Blood Glucose; C-Peptide; Cholecystokinin; Diet; Dose-Response Relationship, Drug; Glucose; Humans; Infusions, Intravenous; Insulin; Male; Pancreatic Polypeptide; Proglumide; Receptors, Cholecystokinin | 1992 |